High expression of tumor necrosis factor a receptors in peripheral blood mononuclear cells of obese type 2 diabetic women

European Cytokine Network

Volumn 15, Issue 1, 2004, Pages 60-66

  Fogeda, Marta ^a   Gallart, Luis ^a   Gutiérrez, Cristina ^a   Vendrell, Joan ^a   Simón, Inmaculada ^a   García España, Antonio ^a   Richart, Cristóbal ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

mTNFR1; mTNFR2 and PBMC

Indexed keywords

GLUCOSE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC OBESITY; FEMALE; HUMAN; HUMAN CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2342656338     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. 12 muscle cells. Am. J. Physiol. Endocrin. Metabol. 276: E849.
2. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. 1994. Tumor necrosis factor alpha inhibits signalling from the insulin receptor. Proc. Natl. Acad. Sci. USA 91: 4854.
3. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. 2001. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrin. Metabol. 280: E745.
4. Saghizaded M, Ong JM, Garvey WT, Henry RR, Kern PA. 1996. The expression of TNFα by human muscle: relationship to insulin resistance. J. Clin. Invest. 97: 1111.
5. Beutler B, Cerami A. 1989. The biology of cachectin/ TNFα primary mediator of the host response. Annu. Rev. Immunol. 7: 625.
6. Old LJ. 1985. Tumor necrosis factor (TNF). Science 230: 630.
7. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV. 1984. Human tumor necrosis factor: precursor structure. Expression and homology to limphotoxin. Nature 312: 724-7.
8. Smith CA, Farrah T, Goodwin RG. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76: 959-62.
9. Tartaglia LA, Goeddel DV. 1992. Two TNF-receptors. Immunol. Today 13: 151-3.
10. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. 1992. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors, J. Exp. Med. 175: 323-9.
11. Fernández-Real JM, Broch M, Ricart W, Gutiérrez C, Casamitjana R, Vendrell J, Richart C. 1998. Plasma levels of the soluble fraction of Tumor Necrosis Factor Receptor-2 and insulin resistance. Diabetes 47: 1757-62.
12. Fernandez-Real JM, Lainez B, Vendrell J, Rigla M, Castro A, Peñarroja G, Broch M, Pérez A, Richart C, Engel P, Ricart W. 2002. Shedding of TNFα receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus. Am. J. Physiol. Endocrin. Metabol. 282: 952-9.
13. Cseh K, Winkler G, Melczer Z, Baranyi E. 2000. The role of tumor necrosis factor (TNF)-α resistance in obesity and insulin resistance. Diabetologia 43: 525.
14. Hancu N, Netea MG, Baciu I. 1998. Hight glucose concentrations increase the tumor necrosis factor-alpha production capacity by human peripheral blood mononuclear cells. Rom. J. Physiol. 35: 325-30.
15. Morohoshi M, Fujisawa F, Uchimura I, Numano F. 1996. Glucose-dependent Interleukin 6 and Tumor Necrosis Factor production by Human Peripheral Blood Monocytes in vitro. Diabetes 45: 954-959.
16. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola Quagliaro L, Ceriello A, Giugliano A. 2002. Inflammatory cytokine concentrations are acutely increased hyperglycemia in humans: role of oxidative stress. Circulation 15: 2067-2072.
17. World Health Organization: Obesity. 1997. Preventing and managing the global epidemic. Report on a WHO consultation on obesity. Geneva, 3-5 June. WHO/NUT/NCD/98.1. Geneva: WHO.
18. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. 2000. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 23: S4-S19.
19. Chomzynski P, Sacci N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-9.
20. Reiling N, Ulmer AJ, Duchrow M, Ernst M, Flad HD, Hanschidt S. 1994. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur. J. Immunol. 24: 1941-6.
21. Rasmussen R. 2001. Quantification on the LightCycler. Rapid Cycle Real-time PCR. In Methods and Applications, edited by Mener S, Wittwer CT, Nakagawara K. Springer, Heidelberg, p. 21-34.
22. Pickup JC, Crook MA. 1998. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41: 1241-8.
23. Hannan A, Benecke H, Y Le Marchand-Brustel, VS Sunsulic, BB Lowell, JS Flier. 1995. Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes 44: 1266-78.
24. Hotamisligil GS, Shargill NS, Spiegelman BM. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
25. Hotamisligil GS, Spiegelman BM. 1994. TNFα: a key component of obesity-diabetes link. Diabetes 43: 1271-8.
26. Morin CL, Pagliassotti MJ, Windmiller D, Eckel RH. 1997. Adipose tissue-derived tumor necrosis factor-alpha activity is elevated in older rats. J. Gerontol. B. Psychol. Soc. Sci. 52: B190-B195.
27. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. 1995. Increased Adipose Tissue Expression of Tumor Necrosis Factor-α in Human Obesity and Insulin Resistance. J. Clin. Invest. 95: 2409-15.
28. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simbolo RB. 1995. The expression of tumor necrosis factor in adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95: 2111-9.
29. Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM. 1997. Differential Regulation of the p80 Tumor Necrosis Factor Receptor in Human Obesity and Insulin Resistance. Diabetes 46: 451-5.
30. Aderka D, Sorkine P, Abu-Abid S, Lev D, Setton A, Cope AP, Wallach D, Klausner J. 1998. Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Revelance to the pathophysiology of septic shock. J. Clin. Invest. 11: 157-9.
31. Hube F, Birgel M, Lee YM, Hauner H. 1999. Expression pattern of tumor necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 29: 672-8.
32. Bulló M, García-Lorda P, Peinado-Onsurbe J, Hernández M, Del Castillo D, Argilés JM, Salas-Salvadó J. 2002. TNFα expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis. Int. J. Obesity 26: 652-8.
33. Koistinen HA, Bastard JP, Dusserre E, Ebeling P, Zegari N, Andreelli F, Jardel C, Donner M, Meyer L, Moulin P, Hainque B, Riou JP, Laville M, Koivisto VA, Vidal H. 2000. Subcutaneous adipose tissue expression of tumor necrosis factor-α is not associated with whole body insulin resistance in obese non-diabetic or in type-2 diabetic subjects. Eur. J. Clin. Invest. 30: 302-10.
34. Guha M, Bai W, Nadler JL, Natarajan R. 2000. Molecular mechanisms of tumor necrosis factor a gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J. Biol. Chem. 275: 17728-39.
35. Heine RJ, Dekker JM. 2002. Beyond postprandial hyperglycemia: metabolic factors associated with cardiovascular disease. Diabetologia 45: 461-75.
36. Kirwan JP, Krishnan RK, Weaver JA, Del Aguila LF, Evans WJ. 2001. Human aging is associated with altered TNFα production during hyperglycemia and hyperinsulinemia. Am. J. Physiol. Endocrin. Metabol. 281: 1137-43.